20 min listen
Episode 063: Breast Cancer Series, Pt. 8-HER2+, Early Stage Breast Cancer
Episode 063: Breast Cancer Series, Pt. 8-HER2+, Early Stage Breast Cancer
ratings:
Length:
20 minutes
Released:
Jul 5, 2023
Format:
Podcast episode
Description
We continue on our journey through early stage breast cancer, this time turning our attention to HER2+ disease. There is a lot of data in this episode, as you will both hear and see. To make this easier, we highlight key takeaways to make understanding this even easier. Content: - What is HER2? - Discovery of trastuzumab- Data for use of trastuzumab in adjuvant and neoadjuvant setting- Data for use of pertuzumab in adjuvant and neoadjuvant setting - Data and use of trastuzumab emtansine (TDM-1) in the adjuvant setting- Management of HER2+ stage I breast cancer- Highlights of key trials that shape the paradigm of management- Our approach to management ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast
Released:
Jul 5, 2023
Format:
Podcast episode
Titles in the series (100)
Episode 013: Heme/Onc Emergencies, Pt. 2: Brain Mets: Ronak Mistry, Vivek Patel, Dan Hausrath by The Fellow on Call: The Heme/Onc Podcast